CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- Open-market buys, last 90 days
- $21,250
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$21,250. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Lerner Neil Chief Accounting Officer | Purchase | +20,000 | $0.92 | $18K | 420,000 |
| 2026-09-24 | Lerner Neil Chief Accounting Officer | Purchase | +2,500 | $1.14 | $3K | 400,000 |
| 2026-04-29 | Lerner Neil Chief Accounting Officer | Purchase | +15,000 | $1.89 | $28K | 397,500 |
| 2026-04-29 | Anderman Jonathan General Counsel | Purchase | +25,000 | $1.89 | $47K | 196,000 |
| 2026-04-29 | Anderman Jonathan General Counsel | Grant or award | +25,000 | $1.89 | $47K | 196,000 |
| 2026-04-29 | Lerner Neil Chief Accounting Officer | Grant or award | +15,000 | $1.89 | $28K | 397,500 |
| 2026-02-08 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −36,687 | $6.52 | $239K | 6,603,336 |
| 2026-01-09 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −46,777 | $5.35 | $250K | 6,640,023 |
| 2026-01-02 | Shin Barry CFO | Grant or award | +125,000 | $5.17 | $646K | 525,000 |
| 2026-01-02 | Shin Barry CFO | Grant or award · Stock Option (Right to Buy) | +670,000 | 670,000 | ||
| 2026-01-02 | Sirard Cynthia Chief Medical Officer | Grant or award · STOCK OPTION (RIGHT TO BUY) | +1,000,000 | 1,000,000 | ||
| 2026-01-02 | Schuetz Thomas J. CEO | Grant or award | +250,000 | $5.17 | $1.3M | 6,686,800 |
| 2026-01-02 | Schuetz Thomas J. CEO | Grant or award · Stock Option (Right to Buy) | +2,000,000 | 2,000,000 | ||
| 2026-01-02 | Prasad Arjun Chief Commercial Officer | Grant or award · STOCK OPTION (RIGHT TO BUY) | +1,000,000 | 1,000,000 | ||
| 2026-01-02 | LINDAHL RICHARD S Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2026-01-02 | Chiniara Ellen Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2026-01-02 | Lerner Neil Chief Accounting Officer | Grant or award | +62,500 | $5.17 | $323K | 382,500 |
| 2026-01-02 | Lerner Neil Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +435,000 | 435,000 | ||
| 2026-01-02 | GRAY MARY ANN Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2026-01-02 | Boylan James P Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 |
Page 1 of 8 · 143 trades